The pharmaceutical industry relies on a complex web of chemical intermediates to produce life-saving medications. Among these, Methyl (+)-(3R)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methanesulfonylamino)pyrimidin-5-yl]-3-hydroxy-5-oxo-(6E)-heptenoate, bearing the CAS number 147118-39-6, holds a distinguished position. This compound is not just another chemical; it is a cornerstone in the sophisticated process of manufacturing Rosuvastatin, a medication widely prescribed for managing cholesterol levels and mitigating cardiovascular risks.

This molecule, characterized by its intricate structure, is a fine chemical that serves as a key intermediate. Its primary application lies in the synthesis of Rosuvastatin, a highly effective HMG-CoA reductase inhibitor. The precise chemical synthesis of Rosuvastatin demands intermediates of exceptional purity and specific structural configurations. CAS 147118-39-6 perfectly fits this requirement, enabling pharmaceutical manufacturers to achieve the desired stereochemistry and molecular integrity for the active pharmaceutical ingredient (API).

The properties of Methyl (+)-(3R)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methanesulfonylamino)pyrimidin-5-yl]-3-hydroxy-5-oxo-(6E)-heptenoate are critical to its function. Typically appearing as a white powder, its molecular formula is C23H28FN3O6S, with a molecular weight of 493.55. These specifications are vital for quality control and regulatory compliance in pharmaceutical production. The consistent availability of this high-purity intermediate is a significant factor for manufacturers aiming for efficient and cost-effective Rosuvastatin production.

For businesses operating within the pharmaceutical supply chain, understanding where to source this critical raw material is paramount. Companies like NINGBO INNO PHARMCHEM CO., LTD. are dedicated to providing high-quality pharmaceutical intermediates. When looking to purchase this chemical, choosing a reputable supplier like NINGBO INNO PHARMCHEM CO., LTD. ensures product integrity, reliable delivery, and adherence to industry standards, which are all essential for a smooth production process and the ultimate success of the final drug product.

In essence, Methyl (+)-(3R)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methanesulfonylamino)pyrimidin-5-yl]-3-hydroxy-5-oxo-(6E)-heptenoate, or CAS 147118-39-6, is more than just an intermediate; it is a critical enabler of modern cardiovascular therapies. Its role in the chemical synthesis of Rosuvastatin highlights the intricate science and diligent supply chain management required to bring effective medicines to market.